ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · Real-Time Price · USD
14.94
+0.36 (2.47%)
Jul 31, 2026, 4:00 PM EDT - Market closed

ClearPoint Neuro Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
40.6136.9731.3923.9620.5516.3
Revenue Growth
25.99%17.78%31.04%16.56%26.09%27.05%
Gross Profit
25.3222.6919.1213.6113.5311.12
Operating Income
-26.48-24.16-19.73-22.45-16.33-13.37
Net Income
-29.07-25.54-18.91-22.09-16.44-14.41
Earnings Per Share
-1.01-0.90-0.70-0.90-0.68-0.69
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
35.5945.9220.123.1437.4954.11
Total Debt
63.5958.233.5713.9411.9912.28
Net Cash (Debt)
-28-12.3116.549.225.541.83
Net Cash Growth
--79.76%-63.93%-39.02%-
Net Cash Per Share
-0.97-0.430.610.371.052.02

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-25.72-23.93-8.95-13.72-16.17-12.7
Capital Expenditures
-0.98-0.52-0.28-0.72-0.25-0.17
Free Cash Flow
-26.7-24.45-9.23-14.44-16.42-12.87
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
62.33%61.38%60.92%56.83%65.84%68.24%
Operating Margin
-65.20%-65.36%-62.87%-93.70%-79.47%-82.05%
Pretax Margin
-71.46%-68.93%-60.22%-92.21%-79.97%-88.41%
Profit Margin
-71.57%-69.08%-60.25%-92.21%-79.97%-88.41%
FCF Margin
-65.75%-66.12%-29.39%-60.27%-79.90%-78.93%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
11.0310.8713.536.9910.1316.29